-
Co-SAE Multimodal Phototherapy for Head and Neck Cancer
2026-08-20
The reference study develops a near-infrared-triggered cobalt single-atom enzyme anchored on hollow N-doped carbon spheres to integrate photodynamic, photocatalytic, and photothermal therapy. Its central advance is an off-to-on catalytic design in which NIR-generated electrons and heat amplify reactive oxygen species while mild local hyperthermia supports tumor-cell death and tissue preservation.
-
Cisplatin and OSCC Stemness: Assay Logic
2026-08-19
Cisplatin and CDDP are most informative when DNA damage, apoptosis, and cancer stemness are measured together. This guide translates recent OSCC findings into practical assay and xenograft design decisions for resistance-focused cancer research.
-
LEE011 Succinate: CDK Inhibitor Research Guide
2026-08-19
LEE011 succinate is a selective CDK inhibitor used to study CDK4/6-dependent cell cycle regulation and cancer-cell proliferation. Ribociclib succinate has defined solvent and pH-dependent solubility specifications, but clinical oral dosing must not be substituted for an in-vitro concentration.
-
Fluo-4 AM Calcium Assay Kit for Mechanotransduction
2026-08-18
Use live-cell calcium imaging to connect annulus fibrosus scaffold architecture with mechanotransduction, while preserving throughput for biomaterial screening and GPCR programs. This practical guide covers a no-wash workflow, assay controls, optimization parameters, and troubleshooting for reliable Fluo-4 AM measurements.
-
Dhx9 Orchestrates TH17 Autoimmune Transcription
2026-08-18
Su et al. identify the nuclear helicase Dhx9 as a central regulator of TH17 lineage commitment, linking IL-6–STAT3 signaling to chromatin accessibility at the Rorc and Il17 loci. Genetic and pharmacological perturbation reduced TH17 differentiation and autoimmune disease severity in mice, providing a mechanistic framework for studying transcriptional control beyond single-cytokine blockade.
-
Caspase-3 Fluorometric Assay Kit in Therapy Models
2026-08-17
The Caspase-3 Fluorometric Assay Kit provides a practical way to place executioner-caspase activity within treatment-induced cell-death pathways. This guide explains how to interpret DEVD-AFC fluorescence alongside genetic, biochemical, and phenotype-level evidence in hyperthermia–cisplatin research.
-
Caspase-8 Strategy for Translational Research
2026-08-17
Z-IETD-FMK offers a precise pharmacological entry point for separating caspase-8-dependent apoptosis from mitochondrial caspase activity, immune activation, and tissue-level outcomes. This thought-leadership guide connects mechanistic biology, assay design, translational interpretation, and the limits of extrapolating pathway inhibition across disease models.
-
Griseofulvin for Reliable Microtubule Assays
2026-08-16
This scenario-based guide explains how Griseofulvin, SKU B3680, can help researchers control formulation variables, interpret viability changes, and investigate microtubule-linked mechanisms. It combines product specifications with evidence from a flow-cytometric aneugen mechanism study while clearly separating established findings from practical workflow recommendations.
-
DAPT (GSI-IX) Workflows for Notch Research
2026-08-15
DAPT (GSI-IX) provides a practical pharmacological switch for interrogating γ-secretase-dependent Notch signaling and amyloid precursor protein processing. This workflow connects established pathway assays with a human iPSC-derived sensory-neuron model for hypothesis-driven studies of neuronal signaling, HSV-1 latency, cancer biology, and immune regulation.
-
HyperScript RT SuperMix for qPCR in NSCLC
2026-08-14
Learn how HyperScript RT SuperMix for qPCR can support mechanism-driven NSCLC gene expression analysis, from SPI1 validation to metastasis-focused assay design. This guide emphasizes RNA structure, low-input samples, primer strategy, and the critical distinction between mRNA and mature microRNA measurements.
-
Neurotensin: GPCR Trafficking Workflow
2026-08-14
Build a controlled Neurotensin workflow for separating acute NTR1 trafficking from delayed miR-133α responses in gastrointestinal cell models. This practical guide combines peptide handling, time-course design, assay controls, and a clearly bounded transfer of spectral-quality ideas from recent fluorescence research.
-
EV Release in Triple-Negative Breast Cancer
2026-08-13
McNamee et al. systematically evaluated whether distinct extracellular vesicle populations contribute to aggressive trait transfer in triple-negative breast cancer. Their results show that several pathway-directed compounds, including Calpeptin, broadly reduced EV release, while residual vesicles retained some biological activity, supporting the need to target total EV output rather than a presumed single vesicle class.
-
Chlorogenic Acid–Metal Assemblies and Inflammation
2026-08-13
A 2026 Frontiers in Pharmacology study shows that chlorogenic acids can form predominantly 1:1 supramolecular assemblies with iron or copper, producing stronger anti-inflammatory activity than the parent molecules in LPS-stimulated RAW264.7 macrophages. Spectroscopic and mass-spectrometric characterization linked this activity to suppression of NF-κB signaling and reduced iNOS and COX-2 expression, while also defining important limits for translation beyond the in vitro model.
-
Anlotinib Hydrochloride: From Mechanism to Translation
2026-08-12
A translational framework for using Anlotinib hydrochloride to connect receptor-level pharmacology with endothelial assays, pharmacokinetic interpretation, comparative study design, and oncology research strategy.
-
Pregnenolone Carbonitrile: PXR Research Workflows
2026-08-12
Pregnenolone Carbonitrile is a practical benchmark for rodent PXR-driven xenobiotic metabolism, while its compartment-specific effects create opportunities in neurotoxicity and liver fibrosis research. This workflow-focused guide covers solution handling, assay design, mechanistic controls, and troubleshooting without assuming that hepatic responses predict brain outcomes.